Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
Journal article published in 2020 by
Carsten Utoft Niemann 
,
Mark-David Levin,
Julie Dubois,
Sabina Kersting,
Lisbeth Enggaard,
Gerrit J. Veldhuis,
Rogier Mous,
Clemens H. M. Mellink,
Johan A. Dobber,
Christian Bjørn Poulsen,
Henrik Frederiksen,
Ann Mh Janssens,
Ida Schjødt,
Ellen C. Dompeling,
Juha Ranti
and other authors.
,
Mark-David Levin,
Julie Dubois,
Sabina Kersting,
Lisbeth Enggaard,
Gerrit J. Veldhuis,
Rogier Mous,
Clemens H. M. Mellink,
Johan A. Dobber,
Christian Bjørn Poulsen,
Henrik Frederiksen,
Ann Mh Janssens,
Ida Schjødt,
Ellen C. Dompeling,
Juha Ranti
and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 